(HealthDay)—Cannabidiol could be beneficial for the treatment of oral mucositis, although data on its use in dentistry are scarce, according to a review published online Feb. 12 in the Journal of Clinical Pharmacy and Therapeutics. L.F. Cuba, from Pontifical Catholic University of Rio Grande do Sul in Porto Alegre, Brazil, and colleagues conducted a systematic […]

by

Zynerba Pharmaceuticals Inc. ZYNE, -55.71% shares plummeted 53% premarket on Monday after the company said its mid-stage clinical trial for cannabidiol gel in adult epilepsy with focal seizures didn’t meet its primary endpoint or secondary endpoints. The company is working to evaluate the results and determine next steps. Zynerba Pharma emphasized that the therapy, ZYN002, […]

by

A failed clinical trial for Zynerba Pharmaceuticals Inc.’s cannabidiol gel in adult epilepsy sent its stock plummeting 58.5% in heavy morning trade Monday. But the results could reflect well on rival GW Pharmaceuticals PLC GWPH, -2.13%  , a U.K.-based biopharma company that develops cannabinoid medications, said Leerink Partners analyst Paul Matteis. GW Pharma shares surged […]

by

– Epidiolex® NDA submission process underway – – Conference call today at 4:30 p.m. EDT – LONDON and CARLSBAD, Calif., Aug. 07, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (NASDAQ:GWPH) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announces financial results […]

by

Credit: Elena Zhukova At a Paul McCartney concert at San Francisco’s ATT Park in 2010, Matthew Springer, PhD, wasn’t shocked to be surrounded by a haze of marijuana smoke. He was, however, amazed that the audience tolerated it without complaint. … read more at: https://medicalxpress.com/news/2017-06-marijuana-legalization.html

by

A grey-haired woman in her early 60s daintily lifts small trays topped with different varieties of marijuana to her nose, sniffing each of them carefully. “Which one would you recommend for someone with medical issues?” she asks salesman Paul Monot, co-founder of the DrGreen shop in western Switzerland. Posters of bright green cannabis plants advertise […]

by

A failed clinical trial for Zynerba Pharmaceuticals Inc.’s cannabidiol gel in adult epilepsy sent its stock plummeting 58.5% in heavy morning trade Monday. But the results could reflect well on rival GW Pharmaceuticals PLC GWPH, -2.13%  , a U.K.-based biopharma company that develops cannabinoid medications, said Leerink Partners analyst Paul Matteis. GW Pharma shares surged […]

by

Shutterstock On a perfect Silicon Valley Saturday, sunny with a soft breeze, I was sampling wines and cheeses with friends in the Saratoga hills. The conversation turned to startups, familiar territory for everyone at the table. A serial restaurateur who had recently joined a fintech company and an angel investor turned consultant both agreed that startups should […]

by

A medical marijuana oil program approved by the Iowa Legislature might not offer much help to patients with qualifying medical conditions, but advocates say it’s at least a step in the right direction. The measure approved by lawmakers in the final hours of the legislative session Saturday would expand a little-used program now only available […]

by

DNA barcodes reveal that a recently-described butterfly species is actually the female of another species known to science for more than a century Andrew Neild / Florida Museum of Natural History Male Sunburst Cerulean-Satyr butterfly (Caeruleuptychia helios; Weymer, 1911) attracted to bait of fermented fish and urine. Villa Carmen Biological Station, Pilcopata, Cuzco, Peru, April […]

by

SAN DIEGO, Aug. 3, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that its major investment company AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC: AXIM) has entered into a Clinical Study Agreement (CSA) with the University of British Columbia in Canada to begin a […]

by